DR. PORTEOUS & PARTNERS
MAPLE HEALTHCARE, MAPLE HEALTHARE, LISNASKEA HEALTH CENTRE, 44 DRUMHAW PARK, LISNASKEA
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 8 | 11 | 72.7% | |
| HF 4 | 2011 | 11 | 16 | 68.8% | |
| HF 4 | 2012 | 10 | 13 | 76.9% | |
| HF 4 | 2013 | 8 | 10 | 80.0% | |
| HF004 | 2014 | 33 | 45 | 73.3% | |
| HF004 | 2015 | 37 | 46 | 80.4% | |
| HF004 | 2016 | 31 | 43 | 72.1% | |
| HF004 | 2017 | 26 | 39 | 66.7% | |
| HF004 | 2019 | 34 | 45 | 75.6% | |
| HF004 | 2020 | 29 | 37 | 78.4% | |
| HF004 | 2021 | 23 | 33 | 69.7% |
